Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways

• Asıl Yazarlar: Sushma Maharjan (Yazar), Min-Gu Lee (Yazar), So-Young Kim (Yazar), Kyu-Shik Lee (Yazar), Kyung-Soo Nam (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2023-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Considerable emphasis is being placed on combinatorial chemotherapeutic/natural treatments for breast cancer. This study reveals the synergistic anti-tumor activity of morin and Doxorubicin (Dox) co-treatment on MDA-MB-231 triple-negative breast cancer (TNBC) cell proliferation. Morin/Dox treatment...